Sanofi ( NASDAQ: SNY) has entered a share purchase agreement in relation to the sale of a 50% controlling stake in Opella, ...

The pharma signed an agreement handing PE firm CD&R a 50% stake in its Capella unit. Elsewhere, Gilead and Ultragenyx secured ...

The FDA granted orphan designation to Sanofi US Services’ rilzabrutinib as a treatment of autoimmune hemolytic anemia, according to a post to the agency’s website. Discover th ...

Sanofi and CD&R have signed a share purchase agreement for the sale of a 50% stake in the consumer health business.

Sanofi is following in the footsteps of a number of its peers in pharma with a plan to spin off its consumer health business into a separate company and focus its efforts on its prescription drugs ...

Sanofi says the deal announced today will make it the world's number one consumer health company, with expected revenues of around €5.1 billion in 2015 ($5.61 billion) and a global market share ...

In a report released today, Jo Walton from UBS maintained a Buy rating on Sanofi (SNYNF – Research Report), with a price target of €120.00. The company’s shares closed last Tuesday at $105.89.

Sanofi Consumer Healthcare India Ltd share price was down by 0.00% from the previous closing price of ₹4,706.90. Who are peers of Sanofi Consumer Healthcare India Ltd? The peers of Sanofi ...

Sanofi Consumer Healthcare India Limited was incorporated on May 10, 2023, pursuant to a Certificate of Incorporation, issued by the Registrar of Companies, Central Registration Centre.

-Sanofi said on Thursday it would buy back 5 billion euros ($5.21 billion) in shares this year and could be more active with acquisitions in the near term as the drugmaker moves towards selling a ...

The French pharmaceutical company Sanofi SA has received mandatory offers to acquire the Consumer Health division from private equity firms Clayton Dubilier & Rice and PAI Partners. This is reported ...